1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow PEGPH20: new trials by email Literature Review of PEGPH20 trials Research Report on PEGPH20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC PEGPH20, Pembrolizumab - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer | Phase 2 | Unknown | Pancreatic Cancer Research Team | 35 | 2019-05-01 | 2019-05-07 |
Adenocarcinoma (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Pancreatic Cancer Research Team (1)
United States (1)